Ship Healthcare Holdings(JP:3360)
Â¥2,569.00+63.00 (+2.51%)
JP:3360
Ship Healthcare Holdings financials statements
Â¥2,569.00
At close:+63.00 (+2.51%)
Want to see JP:3360 full AI Analyst Report?
Ship Healthcare Holdings (3360) Ratios
1 Followers
Ship Healthcare Holdings Ratios
JP:3360's free cash flow for Q1 2026 was ¥0.00. For the 2026 fiscal year, JP:3360's free cash flow was increased by ¥0.00 and operating cash flow was ¥0.00. See a summary of the company’s cash flow.
| Ratios | Mar 26 | Mar 25 | Mar 24 | Mar 23 | Mar 22 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 1.38 | 1.38 | 1.44 | 1.31 | 1.53 |
| Quick Ratio | 1.23 | 1.23 | 1.29 | 1.17 | 1.38 |
| Cash Ratio | 0.41 | 0.40 | 0.47 | 0.41 | 0.50 |
| Solvency Ratio | 0.09 | 0.10 | 0.09 | 0.08 | 0.08 |
| Operating Cash Flow Ratio | 0.11 | 0.11 | 0.17 | 0.07 | 0.08 |
| Short-Term Operating Cash Flow Coverage | 4.63 | 2.92 | 4.23 | 0.44 | 2.00 |
| Net Current Asset Value | ¥ 37.92B | ¥ 28.04B | ¥ 15.42B | ¥ 6.38B | ¥ 13.77B |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.08 | 0.10 | 0.15 | 0.19 | 0.18 |
| Debt-to-Equity Ratio | 0.20 | 0.26 | 0.42 | 0.58 | 0.52 |
| Debt-to-Capital Ratio | 0.17 | 0.21 | 0.29 | 0.37 | 0.34 |
| Long-Term Debt-to-Capital Ratio | 0.14 | 0.17 | 0.27 | 0.25 | 0.32 |
| Financial Leverage Ratio | 2.55 | 2.56 | 2.77 | 2.98 | 2.83 |
| Debt Service Coverage Ratio | 4.08 | 3.06 | 2.73 | 0.60 | 2.80 |
| Interest Coverage Ratio | 57.13 | 49.68 | 54.64 | 49.87 | 72.46 |
| Debt to Market Cap | 0.14 | 0.20 | 0.30 | 0.32 | 0.33 |
| Interest Debt Per Share | 331.49 | 421.83 | 618.75 | 788.15 | 651.85 |
| Net Debt to EBITDA | -1.63 | -1.10 | -0.91 | -0.24 | -0.47 |
| Profitability Margins | |||||
| Gross Profit Margin | 9.29% | 9.84% | 10.40% | 10.59% | 10.43% |
| EBIT Margin | 3.28% | 3.66% | 3.54% | 3.69% | 4.10% |
| EBITDA Margin | 4.28% | 4.75% | 4.71% | 5.00% | 5.17% |
| Operating Profit Margin | 3.39% | 3.66% | 3.89% | 3.69% | 3.99% |
| Pretax Profit Margin | 3.22% | 3.59% | 3.46% | 3.61% | 4.04% |
| Net Profit Margin | 1.87% | 2.23% | 2.19% | 2.11% | 2.37% |
| Continuous Operations Profit Margin | 1.88% | 2.21% | 2.18% | 2.03% | 2.41% |
| Net Income Per EBT | 57.97% | 62.18% | 63.08% | 58.37% | 58.51% |
| EBT Per EBIT | 94.94% | 98.13% | 89.10% | 97.73% | 101.46% |
| Return on Assets (ROA) | 3.48% | 3.96% | 3.56% | 3.16% | 3.63% |
| Return on Equity (ROE) | 8.87% | 10.15% | 9.88% | 9.42% | 10.29% |
| Return on Capital Employed (ROCE) | 12.86% | 12.80% | 11.93% | 11.43% | 10.98% |
| Return on Invested Capital (ROIC) | 7.34% | 7.60% | 7.23% | 5.46% | 6.33% |
| Return on Tangible Assets | 3.59% | 4.10% | 3.70% | 3.30% | 3.74% |
| Earnings Yield | 6.01% | 8.00% | 7.05% | 5.25% | 6.49% |
| Efficiency Ratios | |||||
| Receivables Turnover | 4.86 | 4.70 | 4.99 | 4.19 | 4.32 |
| Payables Turnover | 3.96 | 3.89 | 5.18 | 3.69 | 3.77 |
| Inventory Turnover | 21.39 | 21.19 | 21.12 | 19.19 | 20.84 |
| Fixed Asset Turnover | 14.32 | 13.33 | 12.04 | 8.79 | 8.87 |
| Asset Turnover | 1.86 | 1.78 | 1.63 | 1.50 | 1.54 |
| Working Capital Turnover Ratio | 9.83 | 9.02 | 9.07 | 8.27 | 6.95 |
| Cash Conversion Cycle | -0.03 | 1.05 | 19.92 | 7.31 | 5.12 |
| Days of Sales Outstanding | 75.15 | 77.62 | 73.09 | 87.09 | 84.46 |
| Days of Inventory Outstanding | 17.06 | 17.23 | 17.28 | 19.02 | 17.51 |
| Days of Payables Outstanding | 92.24 | 93.80 | 70.46 | 98.80 | 96.85 |
| Operating Cycle | 92.21 | 94.85 | 90.38 | 106.11 | 101.97 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | 237.30 | 216.05 | 335.02 | 149.50 | 131.72 |
| Free Cash Flow Per Share | 191.21 | 175.55 | 297.75 | 108.08 | 94.94 |
| Dividend Paid and CapEx Coverage Ratio | 2.26 | 2.39 | 4.23 | 1.81 | 1.72 |
| Capital Expenditure Coverage Ratio | 5.15 | 5.33 | 8.99 | 3.61 | 3.58 |
| Operating Cash Flow Coverage Ratio | 0.73 | 0.52 | 0.55 | 0.19 | 0.20 |
| Operating Cash Flow to Sales Ratio | 0.03 | 0.03 | 0.05 | 0.02 | 0.02 |
| Free Cash Flow Yield | 7.97% | 8.76% | 14.36% | 4.43% | 4.78% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | 16.64 | 12.50 | 14.19 | 19.06 | 15.41 |
| Price-to-Sales (P/S) Ratio | 0.31 | 0.28 | 0.31 | 0.40 | 0.36 |
| Price-to-Book (P/B) Ratio | 1.47 | 1.27 | 1.40 | 1.80 | 1.59 |
| Price-to-Free Cash Flow (P/FCF) Ratio | 12.54 | 11.42 | 6.97 | 22.55 | 20.94 |
| Price-to-Operating Cash Flow Ratio | 10.11 | 9.28 | 6.19 | 16.30 | 15.09 |
| Price-to-Earnings Growth (PEG) Ratio | -1.65 | 1.30 | 0.99 | -21.20 | -20.44 |
| Enterprise Value Multiple | 5.61 | 4.77 | 5.67 | 7.80 | 6.58 |
| Enterprise Value | 172.61B | 153.52B | 168.54B | 223.03B | 174.98B |
| EV to EBITDA | 5.61 | 4.77 | 5.67 | 7.80 | 6.58 |
| EV to Sales | 0.24 | 0.23 | 0.27 | 0.39 | 0.34 |
| EV to Free Cash Flow | 9.72 | 9.27 | 6.00 | 21.87 | 19.53 |
| EV to Operating Cash Flow | 7.83 | 7.53 | 5.33 | 15.81 | 14.08 |
| Tangible Book Value Per Share | 1514.72 | 1457.90 | 1358.00 | 1218.49 | 1197.27 |
| Shareholders’ Equity Per Share | 1626.24 | 1580.04 | 1478.72 | 1357.04 | 1253.72 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | 0.42 | 0.38 | 0.37 | 0.44 | 0.40 |
| Revenue Per Share | 7730.83 | 7188.42 | 6687.74 | 6065.54 | 5451.52 |
| Net Income Per Share | 144.18 | 160.33 | 146.15 | 127.85 | 129.01 |
| Tax Burden | 0.58 | 0.62 | 0.63 | 0.58 | 0.59 |
| Interest Burden | 0.98 | 0.98 | 0.98 | 0.98 | 0.99 |
| Research & Development to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A to Revenue | 0.06 | 0.06 | 0.00 | 0.00 | 0.00 |
| Stock-Based Compensation to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Income Quality | 1.65 | 1.35 | 2.29 | 0.68 | 0.60 |
Currency in JPY
